Ayala Pharmaceuticals Inc (ADXS)

[blueyedcatch]

50.00 a share is a lousy 2.5 billion,and NEO and HOT should be able to get Adxs`s market cap there,with or without Axal. Amgn`s running NEO,so the odds of Adxs receiving all it`s slated Milestones from them is pretty darn good,never mind that Amgn will be driving the bus,not Adxs,and I`m sure their connections At the FDA and the EU are much more established then Adxs`s. We still need Merck and BMY to have skin in,so let`s see if Ken can leverage a HOT app deal or 2,from them. Amgn might just pay for the HOT app for lung to keep it from any competition,and then Merck might follow with PSA for HOT. I`m curious to see if the next one will be Cervix HOT,and then we get BMY. The Adxs story and it`s potential of being a SOC for many solid cancer types,is far from over.